Plasma 5α-androstane-3α,17βdiol, an endogenous steroid that positively modulates GABA(A) receptor function, and anxiety: A study in menopausal women

Psychoneuroendocrinology

Volumn 25, Issue 7, 2000, Pages 659-675

  Barbaccia, M L ^a   Lello, S ^a   Sidiropoulou, T ^a   Cocco, T ^a   Sorge, R P ^a   Cocchiarale, A ^a   Piermarini, V ^a   Sabato, A F ^a   Trabucchi, M ^a   Romanini, C ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

3 hydroxy 5 pregnan 20 one; 5 androstane 3 ,17 diol; Anxiety; Dehydroepiandrosterone; Menopause; Progesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; PRASTERONE; PROGESTERONE; ANDROSTANE-3,17-DIONE; ANDROSTANEDIONE; DRUG DERIVATIVE; ETIOCHOLANOLONE;

ADULT; ALLOSTERISM; ANXIETY; ARTICLE; BODY MASS; CLINICAL ARTICLE; DEPRESSION; FEMALE; GABAERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MENOPAUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RATING SCALE; SCORING SYSTEM; SELF EVALUATION; STEROID BLOOD LEVEL; BLOOD; CLIMACTERIUM; MIDDLE AGED; PATHOPHYSIOLOGY; PERSONALITY TEST; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANXIETY; CLIMACTERIC; DEPRESSION; ETIOCHOLANOLONE; FEMALE; HUMANS; MIDDLE AGED; PERSONALITY INVENTORY; RECEPTORS, GABA-A;

EID: 0033624615     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(00)00017-2     Document Type: Article

References (61)

1. A receptor function after acute stress. Neuroendocrinology. 63:1996;166-172.
2. Baulieu E.-E., Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proceedings of the National Academy of Sciences USA. 95:1998;4089-4091.
3. Biggs J.T., Wylie L.T., Zigler V.E. Validity of the Zung self-rating depression scale. British Journal of Psychiatry. 132:1978;381-385.
4. Bixo M., Andersson A., Winblad B., Purdy R.H., Backstrom T. Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Research. 764(1-2):1997;173-178.
5. Celotti F., Melcangi R., Martini L. The 5α-reductase in the brain: Molecular aspects and relation to brain function. Frontiers in Neuroendocrinology. 13:1992;163-215.
6. Cheney D., Uzunov D., Costa E., Guidotti A. Gas chromatographic-mass fragmentographic quantitation of 3α-hydroxy-5α-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. Journal of Neuroscience. 15:1995;4641-4650.
7. Compagnone N.A., Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proceedings of the National Academy of Sciences USA. 95:1998;4678-4683.
8. A receptor. Neuroscience. 45:1991;127-135.
9. Dorow R., Horowski R., Paschelke G., Amin M., Braestrup C. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. The Lancet. 41:1983;98-99.
10. Flood J.F., Smith G.E., Roberts E. Dehydroepiandrosterone and its sulfate derivative enhance memory retention in mice. Brain Research. 447:1988;269-278.
11. Friess E., Trachsel L., Guldner J., Schier T., Steiger A., Holsboer F. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. American Journal of Physiology. 268:1995;E107-E113.
12. Frye C.A., Duncan J.E., Basham M., Erskine M.S. Behavioral effects of 3-alpha androstanediol. II: Hypothalamic and preoptic area actions via a GABAergic mechanism. Behavioral Brain Research. 79(1-2):1996;119-130.
13. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., Mc Ewen B.S. Steroid modulation of the chloride ionophore in rat brain: stucture-activity requirements, regional dependence and mechanism of action. Journal of Pharmacology and Experimental Therapeutics. 246:1988;803-812.
14. Gitlin M.J., Pasnau R.O. Psychiatric syndromes linked to reproductive function in women: A review of current knowledge. American Journal of Psychiatry. 146(11):1989;1413-1422.
15. A receptor channel: a mechanism, for interaction with a multitude of central nervous system functions. Mohler H.C., Da Prada M. The Challenge of Neuropharmacology. 1994;15-39 Éditions Roche, Basel.
16. Hay A.G., Bancroft J., Johnstone E.C. Affective symptoms in women attending a menopause clinic. British Journal of Psychiatry. 164:1994;513-516.
17. Hellerstein D.J., Yanowitch P., Rosenthal J., Samstag L.W., Maurer M., Kasch K., Burrows L., Poster M., Cantillon M., Winston A. A randomized double blind study of fluoxetine versus placebo in the treatment of dysthymia. American Journal of Psychiatry. 150(8):1993;1169-1175.
18. Heuser I., Deuschle M., Luppa P., Schweiger U., Standhardt H., Weber B. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. Journal of Clinical Endocrinology and Metabolism. 83(9):1998;3130-3133.
19. Imamura M., Prasad C. Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochemical and Biophysical Research Communications. 243:1998;771-775.
20. Jones D.L., James V.H. Determination of dehydroepiandrosterone and dehydroepiandrosterone sulfate in blood and tissue. Studies in normal women and women with breast or endometrial cancer. Journal of Steroid Biochemistry. 26(1):1987;151-159.
21. Kalmijn S., Launer L.J., Stolk R.P., deJong F.H., Pols H.A., Hofman A., Breteler M.M., Lamberts S.W. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. Journal of Clinical Endocrinology and Metabolism. 83(10):1998;3487-3492.
22. Kash S.F., Tecott L.H., Hodge C., Baekkeskov S. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65 kDa isoform of glutamic acid decarboxylase. Proceedings of the National Academy of Sciences USA. 96:1999;1698-1703.
23. Labrie F., Belanger A., Cusan L., Gomez J.L., Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. Journal of Clinical Endocrinology and Metabolism. 82(8):1997;2409-2418.
24. A receptor function. Trends in Pharmacological Sciences. 16:1995;295-303.
25. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.J., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
26. Majewska M.D. Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory and affect. Bellino F.L., Daynes R.A., Hornsby P.J., Lavrin D.H., Nestler J.E. Dehydroepiandrosterone (DHEA) and Aging. Annals of The New York Academy of Sciences. 774:1995;111-120 The New York Academy of Sciences, New York.
27. Mason B.J., Kocsis J.H., Leon A.C., Thompson S., Frances A.J., Morgan R.O., Parides M.K. Measurement of severity and treatment response in dysthymia. Psychiatric Annals. 23(11):1993;625-631.
28. Matsumoto K., Uzunova V., Pinna G., Taki K., Uzunov D.P., Watanabe H., Mienville J.M., Guidotti A., Costa E. Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss. Neuropharmacology. 38(7):1999;955-963.
29. McEwen B.S. Non genomic and genomic effects of steroids on neural activity. Trends in Pharmacological Sciences. 12(4):1991;141-147.
30. McLachlan J.A., Serkin C.D., Bakouche O. Dehydroepiandrosterone modulation of lipopolysaccharide stimulated monocyte cytotoxicity. Journal of Immunology. 156:1996;328-335.
31. Melchior C.L., Ritzman R.F. Dehydroepiandrosterone enhances the hypnotic and hypothermic effects of ethanol and pentobarbital. Pharmacology Biochemistry and Behavior. 43:1992;223-227.
32. Melchior C.L., Ritzman R.F. Dehydroepiandrosterone is an anxiolitic in mice on the plus maze. Pharmacology Biochemistry and Behavior. 47:1994;437-441.
33. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Pelletier G., Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacological Reviews. 51(1):1999;63-81.
34. 3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proceedings of the National Academy of Sciences USA. 92:1995;3774-3778.
35. Morrow A.L., Pace J.R., Purdy R.H., Paul S.M. Characterization of steroid interaction with γ-aminobutyric acid receptor-gated chloride channels: evidence for multiple steroid recognition sites. Molecular Pharmacology. 37:1990;263-270.
36. Mortola J.F., Yen S.S.C. The effects of oral dehydroepiandrosterone on endocrine metabolic parameters in postmenopausal women. Journal of Clinical Endocrinology and Metabolism. 71(3):1990;696-704.
37. Orentreich N., Brind J.L., Ritzler R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism. 59:1984;551-555.
38. Pariser S.F. Women and mood disorders, Menarche to menopause. Annals of Clinical Psychiatry. 5(4):1993;249-254.
39. Paul S.M., Purdy R.H. Neuroactive steroids. Federation of the American Society of Experimental Biology Journal. 6:1992;2311-2322.
40. Pavlov E.P., Harman S.M., Chrousos G.P., Loriaux D.L., Blackman M.R. Responses of plasma adrenocorticotropin, cortisol and dehydroepiandrosterone to ovine corticotropin releasing hormone in healthy aging men. Journal of Clinical Endocrinology and Metabolism. 62:1986;767-772.
41. Pearlstein T.B. Hormones and depression: What are the facts about premenstrual syndrome, menopause and hormone replacement therapy. American Journal of Obstetrics and Gynecology. 175(2):1995;646-653.
42. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression: hypothalamic pituitary adrenal axis. Psychiatric Clinics of North America. 21(2):1998;293-307.
43. Prasad A., Imamura M., Prasad C. Dehydroepiandrosterone decreases behavioral despair in high but not low anxiety rats. Pharmacology Biochemistry and Behavior. 62(5):1997;1053-1057.
44. Purdy R.H., Morrow A.L., Blinn J.R., Paul S.M. Synthesis, metabolism and pharmacological activity of 3α-hydroxysteroids which potentiate GABA receptor mediated chloride ion uptake in cerebral cortical synaptoneurosoms. Journal of Medicinal Chemistry. 33:1990;1572-1581.
45. Qin K.N., New M.I., Cheng K.C. Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3alpha-hydroxysteroid-dehydrogenase. Journal of Steroid Molecular Biology. 46(6):1993;673-679.
46. Rao P.N., Khan A.H., Moore P.H. Jr. Synthesis of new steroid haptens for radio-immunoassay. Part III. 15beta-carboxyethylmercaptosteroid bovine serum albumin conjugates. Specific antisera for radioimmunoassay of 5alpha-dihydrotestostrone, 5alpha-androstane-3beta,17beta-diol and 5alpha-androstane-3alpha,17beta-diol. Steroids. 29(2):1977;171-184.
47. A receptor at sites on the N-terminal side of the middle of TM2. Neuroreport. 9(3):1998;379-383.
48. Robel P., Baulieu E.-E. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Bellino R.L., Daynes R.A., Hornsby P.J., Lavrin D.H., Nestler J.E. Dehydroepiandrosterone (DHEA) and Aging, Annals of The New York Academy of Sciences. 774:1995;82-110 The New York Academy of Sciences, New York.
49. Romeo E., Strohle A., Spalletta G., di Michele F., Hermann B., Holsboer F., Pasini A., Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. American Journal of Psychiatry. 155:1998;910-913.
50. Roscetti G., Del Carmine R., Trabucchi M., Massotti M., Purdy R.H., Barbaccia M.L. Modulation of neurosteroid synthesis/accumulation by L-ascorbic acid in rat brain tissue: inhibition by selected serotonin antagonists. Journal of Neurochemistry. 71(3):1998;1108-1117.
51. Rubino S., Stomati M., Bersi C., Casarosa E., Luisi M., Petraglia F., Genazzani A.R. Neuroendocrine effect of a shorm term treatment with DHEA in postmenopausal women. Maturitas. 28(3):1998;251-257.
52. Schmidt P.J., Roca C.A., Rubinow D.R. Clinical evaluation in studies of perimenopausal women: position paper. Psychopharmacology Bulletin. 34(3):1998;309-311.
53. A receptor complex. 28th Annual Meeting Society for Neuroscience Abstracts Book. 1:1998;346.
54. A receptor complex reveals that it may act via the picrotoxin site. Journal of Pharmacology and Experimental Therapeutics. 282:1997;827-833.
55. Stoffel Wagner B., Watzka M., Steckelbroeck S., Schramm J., Bidlingmaier J.F., Klingmuller D. Expression of 17beta-hydroxysteroid-dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. Journal of Endocrinology. 160(1):1999;119-126.
56. Suzuki T., Suzuki N., Daynes R.A., Engleman E.G. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clinical Immunology and Immunopatology. 61:1991;202-211.
57. Thomas G., Frenoy N., Legrain S., Sebag Lanoe R., Baulieu E.-E., Debuire B. Serum dehydroepiandrosterone sulfate levels as an individual marker. Journal of Clinical Endocrinology and Metabolism. 79(5):1994;1273-1276.
58. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proceedings of the National Academy of Sciences USA. 95:1998;3239-3244.
59. Wiley J.L. Behavioral pharmacology of N-methyl-D-aspartate antagonists: implications for the study and pharmacotherapy of anxiety and schizophrenia. Experimental and Clinical Psychopharmacology. 5(4):1997;365-374.
60. Yaffe K., Ettinger B., Pressman A., Seeley D., Whooley M., Schaefer C., Cunnings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biological Psychiatry. 43:1998;694-700.
61. Zung W.W., Richards C.B., Short M.J. Self-rating depression scale in an outpatient clinic: further validation of the SDS. Archives of General Psychiatry. 13:1965;508-515.